Jesus Delgado-Calle
Concepts (184)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Osteocytes | 18 | 2023 | 221 | 5.050 |
Why?
| Bone Morphogenetic Proteins | 10 | 2020 | 64 | 3.560 |
Why?
| Bone and Bones | 11 | 2023 | 523 | 2.440 |
Why?
| Bone Resorption | 9 | 2022 | 326 | 2.340 |
Why?
| Osteoclasts | 8 | 2023 | 472 | 2.330 |
Why?
| Osteogenesis | 11 | 2023 | 381 | 2.250 |
Why?
| Bone Diseases | 4 | 2023 | 108 | 2.230 |
Why?
| Receptors, Notch | 3 | 2022 | 28 | 2.170 |
Why?
| Parathyroid Hormone | 5 | 2022 | 215 | 2.040 |
Why?
| Multiple Myeloma | 8 | 2023 | 3024 | 1.790 |
Why?
| Osteoblasts | 10 | 2022 | 526 | 1.670 |
Why?
| Signal Transduction | 11 | 2022 | 1754 | 1.580 |
Why?
| Bone Remodeling | 5 | 2021 | 180 | 1.560 |
Why?
| DNA Methylation | 10 | 2016 | 575 | 1.440 |
Why?
| RANK Ligand | 6 | 2018 | 183 | 1.410 |
Why?
| Cell Communication | 3 | 2022 | 70 | 1.390 |
Why?
| Genetic Markers | 9 | 2020 | 117 | 1.200 |
Why?
| Osteolysis | 3 | 2022 | 88 | 1.150 |
Why?
| Adaptor Proteins, Signal Transducing | 11 | 2020 | 208 | 1.140 |
Why?
| Bone Marrow Cells | 4 | 2021 | 234 | 1.140 |
Why?
| Osteoporosis | 5 | 2016 | 165 | 1.100 |
Why?
| Bone Neoplasms | 2 | 2017 | 191 | 1.060 |
Why?
| Receptor, Parathyroid Hormone, Type 1 | 3 | 2022 | 32 | 0.950 |
Why?
| Epigenesis, Genetic | 5 | 2016 | 399 | 0.890 |
Why?
| Azacitidine | 5 | 2016 | 37 | 0.840 |
Why?
| Animals | 22 | 2023 | 14435 | 0.790 |
Why?
| Wnt Signaling Pathway | 6 | 2023 | 94 | 0.780 |
Why?
| Mice | 17 | 2023 | 6436 | 0.720 |
Why?
| Osteoporotic Fractures | 3 | 2014 | 11 | 0.700 |
Why?
| Gene Deletion | 2 | 2017 | 296 | 0.680 |
Why?
| Cell Line, Tumor | 6 | 2023 | 1542 | 0.650 |
Why?
| Down-Regulation | 3 | 2016 | 392 | 0.650 |
Why?
| Matrix Metalloproteinase 14 | 1 | 2018 | 5 | 0.650 |
Why?
| Adipogenesis | 3 | 2017 | 52 | 0.640 |
Why?
| Hip Fractures | 3 | 2014 | 52 | 0.640 |
Why?
| Bone Marrow | 2 | 2020 | 415 | 0.640 |
Why?
| Adipocytes | 2 | 2019 | 132 | 0.600 |
Why?
| Gene Expression Regulation | 3 | 2014 | 1075 | 0.600 |
Why?
| Osteoarthritis, Hip | 2 | 2013 | 27 | 0.560 |
Why?
| Osteoprotegerin | 3 | 2016 | 57 | 0.550 |
Why?
| Cellular Microenvironment | 1 | 2016 | 27 | 0.550 |
Why?
| Humans | 34 | 2023 | 54132 | 0.530 |
Why?
| Cell Line | 6 | 2020 | 1166 | 0.500 |
Why?
| Stress, Mechanical | 1 | 2013 | 95 | 0.460 |
Why?
| Disease Progression | 3 | 2021 | 915 | 0.440 |
Why?
| Osteitis Deformans | 2 | 2023 | 3 | 0.430 |
Why?
| Hyperostosis | 2 | 2022 | 4 | 0.410 |
Why?
| Nitric Oxide | 1 | 2013 | 298 | 0.400 |
Why?
| Mice, Knockout | 4 | 2018 | 941 | 0.400 |
Why?
| Cell Lineage | 1 | 2011 | 94 | 0.400 |
Why?
| Alkaline Phosphatase | 1 | 2011 | 101 | 0.390 |
Why?
| Fractures, Bone | 1 | 2012 | 118 | 0.390 |
Why?
| Gene Expression Regulation, Enzymologic | 1 | 2011 | 209 | 0.360 |
Why?
| beta Catenin | 3 | 2022 | 102 | 0.350 |
Why?
| CpG Islands | 4 | 2016 | 104 | 0.340 |
Why?
| Cell Differentiation | 7 | 2023 | 717 | 0.330 |
Why?
| Neoplasms | 1 | 2017 | 1309 | 0.300 |
Why?
| Fibroblast Growth Factors | 2 | 2020 | 59 | 0.290 |
Why?
| Disease Models, Animal | 4 | 2021 | 1645 | 0.280 |
Why?
| Glycoproteins | 2 | 2016 | 132 | 0.280 |
Why?
| Mice, Inbred C57BL | 3 | 2022 | 2021 | 0.270 |
Why?
| Aged, 80 and over | 7 | 2016 | 3442 | 0.260 |
Why?
| Weight-Bearing | 2 | 2016 | 57 | 0.250 |
Why?
| DNA, Circular | 1 | 2022 | 22 | 0.220 |
Why?
| Wnt Proteins | 1 | 2023 | 110 | 0.220 |
Why?
| Genome | 1 | 2022 | 74 | 0.220 |
Why?
| Clodronic Acid | 1 | 2021 | 20 | 0.210 |
Why?
| X-Ray Microtomography | 1 | 2021 | 83 | 0.200 |
Why?
| Female | 11 | 2022 | 28437 | 0.200 |
Why?
| Gene Expression | 4 | 2023 | 667 | 0.200 |
Why?
| Xenograft Model Antitumor Assays | 1 | 2021 | 219 | 0.200 |
Why?
| Transcription, Genetic | 2 | 2013 | 419 | 0.190 |
Why?
| Intercellular Signaling Peptides and Proteins | 3 | 2016 | 123 | 0.190 |
Why?
| Bone Density Conservation Agents | 1 | 2021 | 81 | 0.190 |
Why?
| Proteomics | 1 | 2023 | 341 | 0.190 |
Why?
| Molecular Sequence Data | 2 | 2013 | 996 | 0.190 |
Why?
| Neoplasm Invasiveness | 1 | 2021 | 294 | 0.180 |
Why?
| Cells, Cultured | 4 | 2018 | 1755 | 0.180 |
Why?
| Vascular Endothelial Growth Factor A | 1 | 2020 | 231 | 0.180 |
Why?
| Aged | 8 | 2016 | 10059 | 0.180 |
Why?
| Aging | 2 | 2016 | 786 | 0.180 |
Why?
| Insulin-Like Growth Factor I | 1 | 2020 | 138 | 0.180 |
Why?
| Neovascularization, Pathologic | 1 | 2020 | 172 | 0.180 |
Why?
| Coculture Techniques | 1 | 2019 | 158 | 0.170 |
Why?
| Gene Expression Profiling | 2 | 2013 | 1138 | 0.150 |
Why?
| Dose-Response Relationship, Drug | 1 | 2021 | 1478 | 0.150 |
Why?
| Gene Regulatory Networks | 1 | 2018 | 125 | 0.150 |
Why?
| Molecular Targeted Therapy | 1 | 2017 | 130 | 0.150 |
Why?
| 5-Methylcytosine | 1 | 2016 | 18 | 0.140 |
Why?
| Mice, Transgenic | 4 | 2023 | 662 | 0.140 |
Why?
| Extracellular Matrix Proteins | 1 | 2016 | 75 | 0.140 |
Why?
| Neoplasm Metastasis | 1 | 2017 | 252 | 0.140 |
Why?
| Organ Size | 1 | 2016 | 245 | 0.140 |
Why?
| DNA | 2 | 2022 | 582 | 0.140 |
Why?
| Lipids | 1 | 2017 | 179 | 0.140 |
Why?
| Stromal Cells | 2 | 2019 | 80 | 0.140 |
Why?
| Calcification, Physiologic | 2 | 2016 | 41 | 0.140 |
Why?
| Cell Proliferation | 3 | 2016 | 1099 | 0.130 |
Why?
| Sequence Analysis, DNA | 2 | 2014 | 277 | 0.130 |
Why?
| Cell Survival | 1 | 2017 | 661 | 0.130 |
Why?
| Dexamethasone | 1 | 2017 | 448 | 0.130 |
Why?
| Oligonucleotide Array Sequence Analysis | 2 | 2014 | 473 | 0.130 |
Why?
| Receptors, Parathyroid Hormone | 1 | 2014 | 25 | 0.130 |
Why?
| Pulsatile Flow | 1 | 2013 | 18 | 0.120 |
Why?
| Culture Media, Conditioned | 1 | 2013 | 52 | 0.120 |
Why?
| Glucocorticoids | 1 | 2016 | 276 | 0.120 |
Why?
| Tumor Necrosis Factor-alpha | 1 | 2016 | 436 | 0.120 |
Why?
| Stem Cells | 1 | 2014 | 192 | 0.110 |
Why?
| Promoter Regions, Genetic | 2 | 2014 | 526 | 0.110 |
Why?
| DNA Modification Methylases | 1 | 2013 | 32 | 0.110 |
Why?
| Hallux Valgus | 1 | 2012 | 4 | 0.110 |
Why?
| Transfection | 1 | 2013 | 410 | 0.110 |
Why?
| Models, Biological | 1 | 2016 | 824 | 0.110 |
Why?
| Up-Regulation | 1 | 2014 | 514 | 0.110 |
Why?
| Antibodies, Monoclonal | 1 | 2017 | 560 | 0.110 |
Why?
| Real-Time Polymerase Chain Reaction | 1 | 2013 | 210 | 0.110 |
Why?
| Bone Morphogenetic Protein 2 | 1 | 2012 | 51 | 0.110 |
Why?
| Cloning, Molecular | 1 | 2012 | 205 | 0.110 |
Why?
| PHEX Phosphate Regulating Neutral Endopeptidase | 1 | 2011 | 1 | 0.100 |
Why?
| Sequence Deletion | 1 | 2012 | 101 | 0.100 |
Why?
| Genome-Wide Association Study | 1 | 2013 | 198 | 0.100 |
Why?
| Receptor Activator of Nuclear Factor-kappa B | 1 | 2011 | 32 | 0.100 |
Why?
| Laser Capture Microdissection | 1 | 2011 | 7 | 0.100 |
Why?
| HEK293 Cells | 1 | 2012 | 248 | 0.100 |
Why?
| Calibration | 1 | 2011 | 59 | 0.100 |
Why?
| Cytokines | 1 | 2014 | 678 | 0.100 |
Why?
| Cell Count | 1 | 2011 | 181 | 0.100 |
Why?
| Blood Proteins | 1 | 2011 | 101 | 0.100 |
Why?
| Receptors, Glucocorticoid | 1 | 2010 | 48 | 0.100 |
Why?
| Transcription Factor AP-1 | 1 | 2010 | 65 | 0.100 |
Why?
| MicroRNAs | 1 | 2014 | 387 | 0.090 |
Why?
| Nuclear Proteins | 1 | 2012 | 252 | 0.090 |
Why?
| Protein Binding | 1 | 2012 | 743 | 0.090 |
Why?
| Base Sequence | 1 | 2011 | 732 | 0.090 |
Why?
| Polymerase Chain Reaction | 1 | 2011 | 533 | 0.090 |
Why?
| Apoptosis | 1 | 2016 | 1306 | 0.090 |
Why?
| Immunohistochemistry | 1 | 2011 | 1097 | 0.080 |
Why?
| Antineoplastic Agents | 1 | 2017 | 1295 | 0.080 |
Why?
| Proteins | 1 | 2011 | 382 | 0.080 |
Why?
| Mitogen-Activated Protein Kinase 1 | 1 | 2008 | 57 | 0.080 |
Why?
| Tissue Scaffolds | 2 | 2019 | 26 | 0.080 |
Why?
| Breast Neoplasms | 1 | 2017 | 1248 | 0.080 |
Why?
| Cohort Studies | 1 | 2011 | 1549 | 0.070 |
Why?
| Primary Cell Culture | 2 | 2019 | 65 | 0.070 |
Why?
| Male | 5 | 2014 | 27350 | 0.070 |
Why?
| Chromatin | 2 | 2016 | 155 | 0.060 |
Why?
| Middle Aged | 3 | 2016 | 13094 | 0.060 |
Why?
| Eukaryotic Cells | 1 | 2022 | 20 | 0.060 |
Why?
| Intracellular Signaling Peptides and Proteins | 1 | 2023 | 153 | 0.050 |
Why?
| Bone Density | 2 | 2015 | 417 | 0.050 |
Why?
| Nucleocapsid Proteins | 1 | 2020 | 2 | 0.050 |
Why?
| Bombyx | 1 | 2019 | 2 | 0.040 |
Why?
| Tumor Microenvironment | 1 | 2020 | 207 | 0.040 |
Why?
| Tissue Engineering | 1 | 2019 | 61 | 0.040 |
Why?
| Phenotype | 1 | 2020 | 822 | 0.040 |
Why?
| Child, Preschool | 2 | 2016 | 4132 | 0.040 |
Why?
| Cyclin D1 | 1 | 2016 | 59 | 0.040 |
Why?
| Calcitriol | 1 | 2016 | 44 | 0.040 |
Why?
| Osteocalcin | 1 | 2016 | 46 | 0.040 |
Why?
| Genome, Human | 1 | 2016 | 132 | 0.030 |
Why?
| Mice, Nude | 1 | 2016 | 284 | 0.030 |
Why?
| Young Adult | 2 | 2016 | 4320 | 0.030 |
Why?
| Twins, Monozygotic | 1 | 2014 | 18 | 0.030 |
Why?
| Microarray Analysis | 1 | 2014 | 83 | 0.030 |
Why?
| Organ Culture Techniques | 1 | 2014 | 53 | 0.030 |
Why?
| Immunoblotting | 1 | 2014 | 134 | 0.030 |
Why?
| Genomics | 1 | 2016 | 309 | 0.030 |
Why?
| Osteosarcoma | 1 | 2014 | 40 | 0.030 |
Why?
| Gene Expression Regulation, Developmental | 1 | 2014 | 150 | 0.030 |
Why?
| Gene Frequency | 1 | 2013 | 120 | 0.030 |
Why?
| Adolescent | 2 | 2016 | 6890 | 0.030 |
Why?
| Protein Processing, Post-Translational | 1 | 2014 | 178 | 0.030 |
Why?
| Bone Lengthening | 1 | 2012 | 5 | 0.030 |
Why?
| Child | 2 | 2016 | 7312 | 0.030 |
Why?
| Histones | 1 | 2014 | 331 | 0.030 |
Why?
| Orthopedic Procedures | 1 | 2012 | 82 | 0.030 |
Why?
| Transcriptome | 1 | 2014 | 347 | 0.030 |
Why?
| Polymorphism, Single Nucleotide | 1 | 2013 | 558 | 0.020 |
Why?
| Quality of Life | 1 | 2014 | 914 | 0.020 |
Why?
| Mitogen-Activated Protein Kinase 3 | 1 | 2008 | 56 | 0.020 |
Why?
| Flow Cytometry | 1 | 2010 | 548 | 0.020 |
Why?
| RNA Interference | 1 | 2008 | 195 | 0.020 |
Why?
| Cell Movement | 1 | 2008 | 276 | 0.020 |
Why?
| Adult | 1 | 2016 | 14196 | 0.010 |
Why?
|
|
Delgado-Calle's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|